IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction

Approximately 3% of the world population is chronically infected with the hepatitis C virus (HCV), with potential development of cirrhosis and hepatocellular carcinoma. Despite the availability of new antiviral agents, treatment remains suboptimal. Genome-wide association studies (GWAS) identified r...

Descripción completa

Detalles Bibliográficos
Autores principales: Bibert, Stéphanie, Roger, Thierry, Calandra, Thierry, Bochud, Murielle, Cerny, Andreas, Semmo, Nasser, Duong, François H.T., Gerlach, Tilman, Malinverni, Raffaele, Moradpour, Darius, Negro, Francesco, Müllhaupt, Beat, Bochud, Pierre-Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2013
Materias:
Brief Definitive Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674704/
https://www.ncbi.nlm.nih.gov/pubmed/23712427
http://dx.doi.org/10.1084/jem.20130012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674704/
https://www.ncbi.nlm.nih.gov/pubmed/23712427
http://dx.doi.org/10.1084/jem.20130012

Ejemplares similares